ClearPoint Neuro, Inc.
Every calculator, already run for CLPT
Open the full toolkit →You have the numbers on CLPT. Get the argument.
A written report on which of these readings actually decide the outcome for ClearPoint Neuro, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
2 analysts covering CLPTAnalyst Price Target Disagreement for ClearPoint Neuro, Inc.
Wall Street's bull case implies +82% from the current price; the bear case implies +60%. Analysts are relatively aligned on CLPT's range.
Ownership & short interest
Insider Trading Activity for CLPT
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro lase…
CLPT — frequently asked
Is CLPT a buy right now?
Wall Street's consensus rating on ClearPoint Neuro, Inc. is Strong Buy across 2 analysts, with a mean price target of $23.50 (+71% vs. the current $13.72). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
When is CLPT's next earnings date?
ClearPoint Neuro, Inc. is next scheduled to report earnings around Nov 5, 2026. A full CLPT research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for ClearPoint Neuro, Inc.?
Analysts covering ClearPoint Neuro, Inc. (CLPT) range from a bear-case target of $22.00 to a bull-case high of $25.00, with a mean consensus target of $23.50 across 2 analysts. The spread of $3.00 (22% of the current price) indicates moderate disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare ClearPoint Neuro, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For ClearPoint Neuro, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full CLPT research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on ClearPoint Neuro, Inc., in minutes. 3 free reports included with every account — no credit card required.